In a challenge brought by Eli Lilly and Company, BBB National Programs’ National Advertising Division recommended that Noom, Inc. modify or discontinue its Microdose GLP-1 RX Program “A Smaller Dose.
Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...
PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today announced that Charles Duhigg – Pulitzer Prize–winning journalist and author of The Power of Habit, ...
Microdosing GLP-1 drugs for weight loss is growing in popularity among Americans looking to save a little money or reduce gastrointestinal side effects. Some 12 percent of American adults are using ...
At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...
This episode recorded live at the Becker’s 16th Annual Meeting features Jennifer Jones, Director of Clinical Solutions, Noom. Here, she explores how GLP-1s should be viewed as part of chronic disease ...
Some of the platforms in the ranking below may offer medications (like Ozempic) that are not approved by the U.S. Food and ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. My Instagram algorithm has decided that I am a woman, and, therefore, I must want to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results